“cystic-fibrosis” Archives

in
Entry Author Date Location
Tour of Texas: Savara, Brainspace, JLabs, InCube, Trinity University 03/07/16 Texas
Austin Biotech Savara Nets $20M in Series C for Phase 3 Study 03/01/16 Texas
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture 12/21/15 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Small Molecules: The Silent Majority of Pharmaceutical Pipelines 11/23/15 Boston
Vertex, CRISPR Tx Team up on Gene Editing Drugs in $105M Pact 10/26/15 Boston
Third Rock, SR One Put $52M Into Decibel to Battle Hearing Loss 10/15/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis 07/02/15 Boston
Cystic Fibrosis Drug Maker Nivalis Therapeutics Has $77M IPO 06/17/15 Boulder/Denver
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
Vertex Teams up With Durham’s Parion in $80M Lung Drug Deal 06/04/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
FDA Panel Backs Vertex’s Two-Drug Combo For Cystic Fibrosis 05/12/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
Rethinking Venture Philanthropy After the Kalydeco Windfall 12/22/14 Boston
Famed Geneticist Altshuler Bolts Broad Institute for Vertex 12/15/14 Boston
Cystic Fibrosis Drug Developer N30 Pharmaceuticals Raises $30M 11/20/14 Boulder/Denver
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
Page 1 of 5 next page »